Literature DB >> 622177

Ascorbate-enhanced cytotoxicity of misonidazole.

P D Josephy, B Palcic, L D Skarsgard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 622177     DOI： 10.1038/271370a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

Review 1.  Ascorbic acid: chemistry, biology and the treatment of cancer.

Authors:  Juan Du; Joseph J Cullen; Garry R Buettner
Journal:  Biochim Biophys Acta       Date:  2012-06-20

Review 2.  Nitroimidazoles as hypoxic cell radiosensitizers and hypoxia probes: misonidazole, myths and mistakes.

Authors:  Peter Wardman
Journal:  Br J Radiol       Date:  2018-03-20       Impact factor: 3.039

3.  Effects of ascorbic acid on alkaline phosphatase activity and hormone responsiveness in the osteoblastic osteosarcoma cell line UMR-106.

Authors:  T Sugimoto; M Nakada; M Fukase; Y Imai; Y Kinoshita; T Fujita
Journal:  Calcif Tissue Int       Date:  1986-09       Impact factor: 4.333

4.  Mitochondria, Energy and Cancer: The Relationship with Ascorbic Acid.

Authors:  Michael J González; Glorivee Rosario-Pérez; Angélica M Guzmán; Jorge R Miranda-Massari; Jorge Duconge; Julio Lavergne; Nadia Fernandez; Norma Ortiz; Ana Quintero; Nina Mikirova; Neil H Riordan; Carlos M Ricart
Journal:  J Orthomol Med       Date:  2010

5.  Sulphydryls, ascorbate and oxygen as modifiers of the toxicity and metabolism of misonidazole in vitro.

Authors:  Y C Taylor; A M Rauth
Journal:  Br J Cancer       Date:  1980-06       Impact factor: 7.640

6.  Ascorbate anion potentiates cytotoxicity of nitro-aromatic compounds under hypoxic and anoxic conditions.

Authors:  C J Koch; R L Howell; J E Biaglow
Journal:  Br J Cancer       Date:  1979-03       Impact factor: 7.640

7.  In vitro metabolism of misonidazole.

Authors:  P D Josephy; B Palcic; L D Skarsgard
Journal:  Br J Cancer       Date:  1981-04       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.